WEST PHARMACEUTICAL SERVICES, INC. (WST) Operating income 2016–2025
WEST PHARMACEUTICAL SERVICES, INC. (WST) annual operating income history from SEC filings — each fiscal year as reported.
$584.9MFY2025 · since FY2016: $195.2M → $584.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $584.9M | +2.6% |
| FY2024 | $569.9M | -15.7% |
| FY2023 | $676.0M | -7.9% |
| FY2022 | $734.0M | -2.4% |
| FY2021 | $752.3M | +84.9% |
| FY2020 | $406.9M | +37.2% |
| FY2019 | $296.6M | +23.4% |
| FY2018 | $240.3M | +6.4% |
| FY2017 | $225.8M | +15.7% |
| FY2016 | $195.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice